#我在Gate广场过新年 This marks a major strategic partnership announced in February 2026 between global asset manager Apollo Global Management and the decentralized finance (DeFi) protocol Morpho.
This is a significant milestone for the crypto industry, as it represents one of the most direct steps taken by a traditional "Wall Street" giant into DeFi governance and infrastructure.
Key Details of the Agreement
Amount: Apollo (and its affiliates) have signed an agreement to purchase up to 90 million MORPHO tokens.
Timeline: This purchase is structured to take place over a 48-month (4-year) period.
Share Ratio: If all 90 million tokens are purchased, Apollo will hold approximately 9% of Morpho's total governance supply.
Value: Based on market prices at the time of the announcement (approximately $1.19-$1.37), the value of the deal is estimated to be between $107 million and $115 million. Why This Matters
Unlike typical institutional investments that involve just holding an asset, this partnership is focused on active protocol participation:
On-Chain Lending: Apollo intends to use Morpho’s infrastructure to co-develop and support on-chain lending markets.
Institutional Validation: This move signals a shift from institutions merely "watching" crypto to actively using DeFi rails for credit and liquidity.
Market Stability: To prevent price volatility, the agreement includes specific ownership caps and trading restrictions (vesting periods) on the tokens Apollo acquires.
Important Distinction: Morpho vs. MorphoSys
It is easy to confuse these two, but they are entirely different entities:
Morpho (MORPHO): A decentralized lending protocol in the crypto space (the subject of this Apollo deal).
MorphoSys AG: A German biotechnology company that was actually acquired by Novartis in 2024 for approximately €2.7 billion. $MORPHO
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
17 Likes
Reward
17
20
Repost
Share
Comment
0/400
EagleEye
· 9h ago
Fantastic post very informative and engaging
Reply0
CryptoChampion
· 02-23 20:03
To The Moon 🌕
Reply0
xxx40xxx
· 02-23 19:16
2026 GOGOGO 👊
Reply0
Crypto_Buzz_with_Alex
· 02-23 19:01
showing rising activity and positive momentum during New Year celebration,
#ApollotoBuy90MMORPHOin4Years
#我在Gate广场过新年
This marks a major strategic partnership announced in February 2026 between global asset manager Apollo Global Management and the decentralized finance (DeFi) protocol Morpho.
This is a significant milestone for the crypto industry, as it represents one of the most direct steps taken by a traditional "Wall Street" giant into DeFi governance and infrastructure.
Key Details of the Agreement
Amount: Apollo (and its affiliates) have signed an agreement to purchase up to 90 million MORPHO tokens.
Timeline: This purchase is structured to take place over a 48-month (4-year) period.
Share Ratio: If all 90 million tokens are purchased, Apollo will hold approximately 9% of Morpho's total governance supply.
Value: Based on market prices at the time of the announcement (approximately $1.19-$1.37), the value of the deal is estimated to be between $107 million and $115 million.
Why This Matters
Unlike typical institutional investments that involve just holding an asset, this partnership is focused on active protocol participation:
On-Chain Lending: Apollo intends to use Morpho’s infrastructure to co-develop and support on-chain lending markets.
Institutional Validation: This move signals a shift from institutions merely "watching" crypto to actively using DeFi rails for credit and liquidity.
Market Stability: To prevent price volatility, the agreement includes specific ownership caps and trading restrictions (vesting periods) on the tokens Apollo acquires.
Important Distinction: Morpho vs. MorphoSys
It is easy to confuse these two, but they are entirely different entities:
Morpho (MORPHO): A decentralized lending protocol in the crypto space (the subject of this Apollo deal).
MorphoSys AG: A German biotechnology company that was actually acquired by Novartis in 2024 for approximately €2.7 billion.
$MORPHO